ClearPoint Neuro, Inc. Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| CLPT | RMD | |
|---|---|---|
| Market Cap | $421.87 million | $32.46 billion |
| Revenue (TTM) | — | $5.65 billion |
| Net Income (TTM) | — | $1.52 billion |
RMD leads on 1 of 1 size & scale factors.
Valuation
| CLPT | RMD | |
|---|---|---|
| P/E Ratio | — | 21.57 |
| Price / Book | 39.15 | 4.93 |
| Price / Sales | — | 5.74 |
RMD leads on 1 of 1 valuation factors.
Profitability
| CLPT | RMD | |
|---|---|---|
| Net Margin | — | 26.94% |
| Return on Equity | — | 23.13% |
CLPT and RMD split the profitability factors evenly.
Dividend
| CLPT | RMD | |
|---|---|---|
| Dividend Yield | — | 1.17% |
| Payout Ratio | — | 25.31 |
CLPT and RMD split the dividend factors evenly.
Risk & Sentiment
| CLPT | RMD | |
|---|---|---|
| Short Interest | 0.16% | 4.04% |
CLPT leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLPT overview, CLPT financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.